A promising field of scientific research that was shut down with the US war on drugs and is now coming back to life. PROF. RICHARD HARVEY, ROYAL COLLEGE OF PSYCHIATRISTS: In the past sort of probably 10, 15 maybe 20 years, new interest in psychedelics has emerged.
PETER MCCUTCHEON: Australia, to the surprise of many, is leading the way with the Therapeutic Goods Administration last year making the shock announcement it would allow clinical use of two psychedelic drugs outside of research trials for specific mental health conditions.DR ANTHONY BLOCH, ASSOC. FOR PSYCHEDELIC PRACTITIONERS: We were absolutely delightfully surprised, make no mistake because we do see the potential of these medicines. PROF. SUSAN ROSSELL, SWINBURNE UNIVERSITY OF TECHNOLOGY: I thought it was premature and it really concerned me about the safety. PETER MCCUTCHEON: In the 12 months after this historic decision, the psychedelic floodgates didn’t open – in fact there’s been barely a trickle to the frustration of man